🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a randomized, double-blind, placebo-controlled trial in de novo kid...
Status
Enrolling By Invitation
Location
Houston Methodist Research Institute
Start Date
2022-07-28
Trial ID
NCT05285878
Treatments Being Tested
The present phase 1b/2 randomised, double-blind, placebo-controlled, two-pa...
Status
Recruiting
Location
University Hospital Düsseldorf
Start Date
2023-04-14
Trial ID
NCT07304843
Treatments Being Tested
The objective of this study was to establish the relative bioavailability o...
Status
Completed
Location
Multiple Locations
Start Date
2008-01
Trial ID
NCT02182284
Multiple myeloma (MM) is a malignancy characterized by uncontrolled prolife...
Status
Terminated
Location
Mount Sinai Health System
Start Date
2024-10-02
Trial ID
NCT06351644
Treatments Being Tested
Previous work has shown that gelatin supplementation could increase collage...
Status
Completed
Location
Biological Sciences
Start Date
2017-10-21
Trial ID
NCT03357432
Treatments Being Tested
A study to compare the pharmacokinetics and food-effect bioavailability of ...
Status
Completed
Location
ICON
Start Date
2016-11-16
Trial ID
NCT03010631
This study aims to evaluate the acceptability of a new non-invasive screeni...
Status
Terminated
Location
Columbia University Irving Medical Center
Start Date
2018-08-01
Trial ID
NCT03366012
Treatments Being Tested
The primary objectives of this study are to assess bronchodilator efficacy ...
Status
Terminated
Location
1184.14.01013 Boehringer Ingelheim Investigational Site
Start Date
2008-04-15
Trial ID
NCT00662740
The present trial is an exploratory study aiming at evaluating the safety, ...
Status
Completed
Location
Unitat de Pneumologia Experimental
Start Date
2018-06-01
Trial ID
NCT03774290
Treatments Being Tested
The ID-Cap System is classified as an ingestion event marker (IEM), a Class...
Status
Completed
Location
Quotient Sciences
Start Date
2018-07-31
Trial ID
NCT03653897
Treatments Being Tested